Click Here for 5% Off Your First Aladdin Purchase!

E-64d - protease inhibitor,98%, high purity , CAS No.88321-09-9, Inhibitor of cathepsin G

  • Moligand™
  • ≥98%
  • protease inhibitor
Item Number
E123225
Grouped product items
SKUSizeAvailabilityPrice Qty
E123225-1mg
1mg
In stock
$45.90
E123225-250μg
250μg
In stock
$13.90
E123225-5mg
5mg
In stock
$98.90
E123225-25mg
25mg
In stock
$246.90
E123225-100mg
100mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$741.90
E123225-250mg
250mg
In stock
$1,669.90

Irreversible cell-permeable cathepsin B and L inhibitor

View related series
cathepsin G Inhibitor

Basic Description

SynonymsAloxistatin|88321-09-9|Loxistatin|E-64D|E 64d|Aloxistatin [INN]|Aloxistatina|Aloxistatine|Aloxistatinum|E64d|EST|L5W337AOUR|CHEMBL63440|Ethyl (+)-(2S,3S)-2,3-epoxy-N-((S)-1-(isopentylcarbamoyl)-3-methylbutyl)succinamate|MLS000028372|E-64-d|NSC-694281|SMR0
Specifications & Purityprotease inhibitor,98%
Storage TempStore at -20°C
Shipped InDry ice
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of cathepsin G

Associated Targets

CTSG Tchem Cathepsin G 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name ethyl (2S,3S)-3-[[(2S)-4-methyl-1-(3-methylbutylamino)-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate
INCHI InChI=1S/C17H30N2O5/c1-6-23-17(22)14-13(24-14)16(21)19-12(9-11(4)5)15(20)18-8-7-10(2)3/h10-14H,6-9H2,1-5H3,(H,18,20)(H,19,21)/t12-,13-,14-/m0/s1
InChi Key SRVFFFJZQVENJC-IHRRRGAJSA-N
Canonical SMILES CCOC(=O)C1C(O1)C(=O)NC(CC(C)C)C(=O)NCCC(C)C
Isomeric SMILES CCOC(=O)[C@@H]1[C@H](O1)C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C
PubChem CID 65663
Molecular Weight 342.43

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

9 results found

Lot NumberCertificate TypeDateItem
K2215750Certificate of AnalysisAug 23, 2024 E123225
K2215752Certificate of AnalysisAug 23, 2024 E123225
K2215778Certificate of AnalysisAug 23, 2024 E123225
K2215827Certificate of AnalysisAug 23, 2024 E123225
K2215833Certificate of AnalysisAug 23, 2024 E123225
K2215862Certificate of AnalysisAug 13, 2024 E123225
J2113254Certificate of AnalysisJul 07, 2023 E123225
B1414010Certificate of AnalysisOct 19, 2022 E123225
E2422094Certificate of AnalysisOct 10, 2022 E123225

Chemical and Physical Properties

Specific Rotation[α]49° (C=1,MeOH)
Melt Point(°C)126 °C

Safety and Hazards(GHS)

Pictogram(s) GHS07
Signal Warning
Hazard Statements

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

Precautionary Statements

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352:IF ON SKIN: wash with plenty of water.

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P271:Use only outdoors or in a well-ventilated area.

P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P403+P233:Store in a well-ventilated place. Keep container tightly closed.

P362+P364:Take off contaminated clothing and wash it before reuse.

P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes.

P337+P317:If eye irritation persists: Get medical help.

P332+P317:If skin irritation occurs: Get medical help.

P319:Get medical help if you feel unwell.

Related Documents

References

1. Barrett AJ, Kembhavi AA, Brown MA, Kirschke H, Knight CG, Tamai M, Hanada K.  (1982)  L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L..  Biochem J,  201  (1): (189-98).  [PMID:7044372]
2. Meara JP, Rich DH.  (1996)  Mechanistic studies on the inactivation of papain by epoxysuccinyl inhibitors..  J Med Chem,  39  (17): (3357-66).  [PMID:8765519]
3. Qin Y et al..  (2019)  Redox-Mediated Endocytosis of a Receptor-Like Kinase during Distal Stem Cell Differentiation Depends on Its Tumor Necrosis Factor Receptor Domain..  Plant Physiol,  181  (3): (1075-1095).  [PMID:31471454]

Solution Calculators